Nitric oxide provides myocardial protection when added to the cardiopulmonary bypass circuit during cardiac surgery: Randomized trial / N. O. Kamenshchikov [et al.]

Уровень набора: The Journal of Thoracic and Cardiovascular SurgeryАльтернативный автор-лицо: Kamenshchikov, N. O., Nikolay Olegovich;Mandel, I. A., Irina Arkadjevna;Podoksenov, Yu. K., Yury Kirilovich;Svirko, Yu. S., Yulia Stanislavovna;Anfinogenova, Ya. J., Linguist, Lecturer of Tomsk Polytechnic University, Doctor of medical sciences, 1970-, Yana JonovnaКоллективный автор (вторичный): Национальный исследовательский Томский политехнический университет, Инженерная школа новых производственных технологий, Научно-образовательный центр Н. М. КижнераЯзык: английский.Резюме или реферат: Objectives - The aim of this pilot study was to elucidate the effects of exogenous nitric oxide <https://www.sciencedirect.com/topics/medicine-and-dentistry/nitric-oxide>(NO) supply to the extracorporeal circulation <https://www.sciencedirect.com/topics/medicine-and-dentistry/extracorporeal-circulation> circuit for cardioprotection <https://www.sciencedirect.com/topics/medicine-and-dentistry/heart-protection> against -ischemiareperfusion injury <https://www.sciencedirect.com/topics/medicine-and-dentistry/reperfusion-injury> during coronary artery bypass grafting <https://www.sciencedirect.com/topics/medicine-and-dentistry/coronary-artery-bypass-graft> (CABG) with cardiopulmonary bypass <https://www.sciencedirect.com/topics/medicine-and-dentistry/cardiopulmonary-bypass> (CPB). Methods -A total of 60 patients with coronary artery disease <https://www.sciencedirect.com/topics/medicine-and-dentistry/coronary-artery-disease> scheduled for CABG with CPB were enrolled in a prospective randomized study. Patients were allocated randomly to receive treatment according to standard or modified CPB protocol where 40-ppm NO was added to the CPB circuit during cardiac surgery <https://www.sciencedirect.com/topics/medicine-and-dentistry/heart-surgery>. The primary endpoint was the measurement of cardiac troponin I <https://www.sciencedirect.com/topics/medicine-and-dentistry/troponin-i> (cTnI). The secondary end points consisted in the measurements of creatine kinase-muscle/brain fraction (CK-MB) and vasoactive inotropic <https://www.sciencedirect.com/topics/medicine-and-dentistry/inotropism> score (VIS).; Results - NO delivered into the CPB circuit had a cardioprotective effect. The level of cTnI was significantly lower in NO-treated group compared with the control group 6 hours after surgery: 1.79 ± 0.39 ng/mL versus 2.41 ± 0.55 ng/mL, respectively (P = .001). The CK-MB value was significantly lower in NO-treated group compared with the control group 24 hours after surgery: 47.69 ± 8.08 U/L versus 62.25 ± 9.78 U/L, respectively (P = .001); and the VIS was significantly lower in the NO-treated group 6 hours after the intervention. Conclusions - NO supply to the CPB circuit during CABG exerted a cardioprotective effect and was associated with lower levels of VIS and cardiospecific blood markers cTnI and CK-MB..Аудитория: .Тематика: электронный ресурс | труды учёных ТПУ | cardioprotection | ischemia-reperfusion injury | nitric oxide | cardiopulmonary bypass | coronary artery bypass grafting | шунтирование | оксид азота | ишемия Ресурсы он-лайн:Щелкните здесь для доступа в онлайн
Тэги из этой библиотеки: Нет тэгов из этой библиотеки для этого заглавия. Авторизуйтесь, чтобы добавить теги.
Оценка
    Средний рейтинг: 0.0 (0 голосов)
Нет реальных экземпляров для этой записи

Title screen

Objectives - The aim of this pilot study was to elucidate the effects of exogenous nitric oxide <https://www.sciencedirect.com/topics/medicine-and-dentistry/nitric-oxide>(NO) supply to the extracorporeal circulation <https://www.sciencedirect.com/topics/medicine-and-dentistry/extracorporeal-circulation> circuit for cardioprotection <https://www.sciencedirect.com/topics/medicine-and-dentistry/heart-protection> against -ischemiareperfusion injury <https://www.sciencedirect.com/topics/medicine-and-dentistry/reperfusion-injury> during coronary artery bypass grafting <https://www.sciencedirect.com/topics/medicine-and-dentistry/coronary-artery-bypass-graft> (CABG) with cardiopulmonary bypass <https://www.sciencedirect.com/topics/medicine-and-dentistry/cardiopulmonary-bypass> (CPB). Methods -A total of 60 patients with coronary artery disease <https://www.sciencedirect.com/topics/medicine-and-dentistry/coronary-artery-disease> scheduled for CABG with CPB were enrolled in a prospective randomized study. Patients were allocated randomly to receive treatment according to standard or modified CPB protocol where 40-ppm NO was added to the CPB circuit during cardiac surgery <https://www.sciencedirect.com/topics/medicine-and-dentistry/heart-surgery>. The primary endpoint was the measurement of cardiac troponin I <https://www.sciencedirect.com/topics/medicine-and-dentistry/troponin-i> (cTnI). The secondary end points consisted in the measurements of creatine kinase-muscle/brain fraction (CK-MB) and vasoactive inotropic <https://www.sciencedirect.com/topics/medicine-and-dentistry/inotropism> score (VIS).

Results - NO delivered into the CPB circuit had a cardioprotective effect. The level of cTnI was significantly lower in NO-treated group compared with the control group 6 hours after surgery: 1.79 ± 0.39 ng/mL versus 2.41 ± 0.55 ng/mL, respectively (P = .001). The CK-MB value was significantly lower in NO-treated group compared with the control group 24 hours after surgery: 47.69 ± 8.08 U/L versus 62.25 ± 9.78 U/L, respectively (P = .001); and the VIS was significantly lower in the NO-treated group 6 hours after the intervention. Conclusions - NO supply to the CPB circuit during CABG exerted a cardioprotective effect and was associated with lower levels of VIS and cardiospecific blood markers cTnI and CK-MB.

Для данного заглавия нет комментариев.

оставить комментарий.